🔎 Trials Near Me

Akèy › Skleroz Miltip › Missouri

Etid klinik pou Skleroz Miltip nan Missouri

8 etid pou Skleroz Miltip ap chèche patisipan nan sit nan Missouri.

Vil nan Missouri

Tèks ofisyèl etid la (Anglè)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • University Health Truman Medical Center, Kansas City
  • ak 6 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  • Washington University, St. Louis, St Louis
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07477639

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06782490

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

  • Research Site, St Louis
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou Aug 25, 2026 · NCT07224373

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

  • Washington University School of Medicine in St. Louis, St Louis
Ap rekriteEtid obsèvasyon
Laj 40 a 70 · Tout sèks · Mizajou Aug 11, 2026 · NCT07758270

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

  • Washington University School of Medicine Neurology Clinical Unit, St Louis
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Jun 15, 2026 · NCT06735248

Smoldering Inflammation in MS

  • Barnes Jewish Center for Clinical Imaging Research, St Louis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 28, 2026 · NCT06591429

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.